## Pharmacological Management of ADHD Symptoms in ASD **Key Point:** Methylphenidate is the first-line pharmacological agent for attention-deficit/hyperactivity symptoms in children with autism spectrum disorder, provided there are no contraindications such as cardiac arrhythmias or severe anxiety. **High-Yield:** In ASD, ADHD-like symptoms (inattention, hyperactivity, impulsivity) are common and often respond to stimulant medications. Methylphenidate has the strongest evidence base for efficacy in this population. ### Mechanism and Efficacy Methylphenidate is a central nervous system stimulant that blocks the reuptake of dopamine and norepinephrine, enhancing attention and reducing hyperactivity. Multiple randomized controlled trials support its use in children with ASD and concurrent ADHD symptoms. ### Dosing Considerations in ASD - Typical starting dose: 5 mg once or twice daily - Titration: Increase by 5 mg every 5–7 days as tolerated - Maximum usual dose: 60 mg/day in divided doses - Children with ASD may require lower doses and show increased sensitivity to side effects **Clinical Pearl:** Always obtain baseline cardiovascular assessment (BP, HR, ECG if indicated) before initiating stimulant therapy, as children with ASD may have comorbid cardiac risk factors. ### Monitoring Parameters - Appetite and weight - Sleep patterns - Heart rate and blood pressure - Behavioral changes (may unmask or exacerbate tics in some children) - Growth velocity (height and weight) **Warning:** Stimulants are NOT first-line for aggression, self-injurious behavior, or irritability in ASD—these require antipsychotics or mood stabilizers. [cite:American Academy of Pediatrics Clinical Practice Guideline on ADHD, 2019]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.